ABSTRACT. Objective. The aim of treatment for attention-deficit/hyperactivity disorder (ADHD) is to decrease symptoms, enhance functionality, and improve well-being for the child and his or her close contacts. However, the measurement of treatment response is often limited to measuring symptoms using behavior rating scales and checklists completed by teachers and parents. Because so much of the focus has been on symptom reduction, less is known about other possible health problems, which can be measured easily using healthrelated quality-of-life (HRQL) questionnaires, which are designed to gather information across a range of health domains. The aim of our study was to measure HRQL in a clinic-based sample of children who had a diagnosis of ADHD and consider the impact of 2 clinical factors, symptom severity and comorbidity, on HRQL. Our specific hypotheses were that parent-reported HRQL would be poorer in children with ADHD than in normative US and Australian pediatric samples, in children with increasing severity of ADHD symptoms, and in children who had diagnoses of comorbid psychiatric disorders.
cally important differences in HRQL. Our study adds new information about the HRQL of children with ADHD in relation to symptom severity and comorbidity. Children with more symptoms of ADHD had worse psychosocial HRQL. Children with multiple comorbid disorders had poorer psychosocial HRQL across a range of domains compared with children with none and 1 comorbid disorder. In addition, compared with children with no comorbidity, psychosocial HRQL was significantly lower in children with ODD/CD and children in the other comorbidity group but not in children with an LD. The demonstration of a differential impact of ADHD on health and well-being in relation to symptom severity and comorbidity has important implications for policies around eligibility for special educational and other supportive services. Because the impact of ADHD is not uniform, decisions about needed supports should incorporate a broader range of relevant indicators of outcome, including HRQL. Although many studies focus on measuring symptoms using rating scales and checklists, in our study, using a multidimensional questionnaire, we were able to show that many areas of health are affected in children with ADHD. We therefore argue that research studies of children with ADHD should include measurement of these broader domains of family impact and child health. A ttention-deficit/hyperactivity disorder (ADHD), one of the most common childhood psychiatric disorders, affects between 3% and 5% of children, according to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV). 1 Boys are 3 times more likely to have ADHD than girls and 6 to 9 times more likely than girls to be seen with ADHD among clinic-referred children. 2 ADHD is a condition characterized by different levels of inattention, hyperactivity, and impulsivity and gives rise to significant academic, social, and emotional problems at home and at school. 2 Academically, children with ADHD often underachieve or fail in school. Socially, they have poor relationships with peers, teachers, and parents. Emotionally, they often have poor self-esteem and are at considerably increased risk for depression, anxiety, and/or delinquent behavior. The extent of comorbidity in children with ADHD is high, as it commonly occurs in association with oppositional defiant disorder (ODD), conduct disorder (CD), learning disabilities (LDs), and other psychiatric conditions such as anxiety disorders and depression. 2, 3 As with most mental health disorders in children, the aim of treatment for ADHD is to decrease symptoms, enhance functionality, and improve well-being for the child and his or her close contacts. However, measurement of treatment response is often limited to measuring a reduction in symptoms using behavior rating scales completed by teachers and parents.
In fact, current guidelines recommend the use of such scales to evaluate and monitor treatment effects. 4 Because so much focus has been on measuring symptom reduction, little research has studied the effects of ADHD on other aspects of a child's health. However, the development of an increasing number of multidimensional health-related quality-of-life (HRQL) questionnaires now afford the opportunity to measure the health of children with ADHD more comprehensively. [5] [6] [7] [8] In the research literature, we are aware of 5 studies that have measured HRQL in children with ADHD. [9] [10] [11] [12] [13] Although these studies provide some information about the level of HRQL experienced by children with ADHD, none have considered the relationship between HRQL and key clinical factors, which we hypothesize will have an important effect on HRQL. The aim of our study was to measure HRQL in a clinic-based sample of children who have a diagnosis of ADHD and consider the impact of 2 clinical factors on HRQL. Our specific hypotheses were that parent-reported HRQL would be poorer in children with ADHD than the general pediatric population, in children with increasing severity of ADHD symptoms, and in children who have diagnoses of comorbid psychiatric disorders.
METHODS

Participants
The sample was recruited from the ADHD clinic at British Columbia Children's Hospital, which is a specialist clinic located at the only tertiary care pediatric facility in the province of British Columbia (Canada). Children who are seen in this clinic come from all parts of the province and are diverse in terms of socioeconomic status and case mix. Although many referred cases have complex diagnostic or management problems, approximately one third of cases are newly identified by family doctors and are not necessarily complex.
A total of 335 children were referred to the ADHD clinic during our 12-month recruitment period (November 2001 to October 2002). Of these, 59 referrals were canceled, 8 parents could not communicate in English, 5 children were redirected to a different clinic within the hospital, 3 children were involved in a different research project, and 1 child died. Of the remaining 259 children, 165 (63.7%) parents completed a study questionnaire. The final study sample included 131 children who had a diagnosis of ADHD (33 did not have ADHD, and for 1, the hospital notes were missing). ADHD subtypes included the following: combined type (n ϭ 88); inattentive type (n ϭ 35); hyperactive (n ϭ 2); and not otherwise specified (n ϭ 6). Family and child characteristics for the sample appear in Table 1 . Our study questionnaire was completed by 116 (93.5%) biological parents, most commonly the child's mother (n ϭ 102; 82.3%). The mean age of children in the study sample was 10 years (SD: 2.8). Boys composed 80.9% (n ϭ 106) of the sample.
Materials
Before a child's appointment, parents are routinely sent a package of questionnaires to complete. For the purposes of our study, the Child Health Questionnaire (CHQ; described below) was included in the package. Symptom severity data came from the Child/Adolescent Symptom Inventory 4 (CSI), one of the questionnaires sent routinely to parents (described below).
CHQ
The CHQ is a multidimensional generic measure of HRQL that can be used with children as young as 5 years. 9 We used the 50-item parent-completed CHQ (CHQ-PF50), which measures 11 domains of health. Physical domains include the following: physical functioning, role/social limitations as a result of physical
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HEALTH-RELATED QUALITY OF LIFE IN CHILDREN WITH ADHD health, bodily pain/discomfort, and general health perception. Psychosocial domains include the following: role/social limitations as a result of emotional-behavioral problems, self-esteem, mental health, general behavior, emotional impact on parent, and time impact on parents. A separate domain measures limitations in family activities. There is also a single-item measure of family cohesion. Scores for the domains and single item range from 0 to 100, with higher scores indicating better HRQL. In addition, summary scores can be derived to measure physical and psychosocial health. The summary scores have a mean of 50 and an SD of 10. The CHQ-PF50 has undergone extensive validation, and normative data are available. 9,14
CSI
These checklists provide information on symptoms for the 3 ADHD subtypes: 9 inattentive and 9 hyperactivity/impulsivity symptoms are listed in 2 separate scales, and both scales together form the combined subtype. [15] [16] [17] [18] The symptom severity approach sums the values of the items ("never" ϭ 0, "sometimes" ϭ 1, "often" ϭ 2, "very often" ϭ 3). The instrument has moderate to high sensitivity for DSM-IV disorders and correlates well with dimensional rating scales such as the Achenbach 19 and semistructured interviews. 20 
Procedure
Ethical approval was obtained from the University of British Columbia and the participating children's hospital. A letter from the head of the ADHD clinic describing the study, a consent form, and the study questionnaire were sent to all new referrals over a 12-month period. A reminder letter and up to 2 additional copies of the questionnaires were sent to nonrespondents. Remaining nonrespondents were contacted by telephone to confirm response status. Each child underwent a comprehensive psychiatric assessment by 1 of 4 child psychiatrists, all of whom have a minimum of 10 years of clinical and research experience with ADHD. Diagnosis was based on LEAD (longitudinal, expert, all data) criteria. 21 Psychoeducational and occupational therapy testing was done as needed. Documentation included a full 5-axis DSM-IV diagnosis based on a comprehensive assessment. Clinical information for each child was extracted from hospital notes.
Data Analysis
To explore relationships between symptom severity scores and comorbidity by gender and age, we used 2 tests, t tests, and Mann-Whitney U tests. Interclass correlation coefficients and paired t tests were computed to examine agreement between parent and teacher CSI data. Mean scores for the CHQ-PF50 were computed and compared with published population norms. Because no population norms are available for Canadian children, comparisons were made with US 9 and Australian 14 norms. Z tests were used to estimate statistical significance, and effect sizes were computed to explore the clinical importance of differences between the ADHD sample and the US norms (Australian SDs were not available). Effect sizes were computed by dividing the mean difference in scores by the population SD. Cohen's guidelines for interpretation (0.2 is small, 0.5 is medium, 0.8 is large) were used. 22 Spearman correlation coefficients were used to examine the relationship between HRQL and ADHD symptom severity. A t test, Mann Whitney U test, or analysis of variance was used to compare mean CHQ-PF50 scores by gender and comorbidity. Effect sizes for these were computed, using the pooled SD. Pearson correlation coefficients identified significant relationships between CHQ-PF50 summary scores and the following variables: annual household income, caregiver education, marital status, child age, child gender, type of ADHD, the presence of comorbidity, type of comorbidity, number of comorbid diagnoses, and parent-and teacher-reported ADHD symptoms. Variables that were significantly related to the summary scores were entered into multiple regression models to examine the proportion of variation explained in HRQL summary scores.
RESULTS
Treatment History
A history of stimulant medication was noted for 59 (45%) children. Ritalin had been prescribed to 54 and Dexedrine to 20 (16 of whom had also had Ritalin). At the time of their appointment, 92 (70.2%) children were not on medication, 36 (27.5%) were receiving medication, and for 3 (2.3%) children, the medication status was unknown. Just over half of the children on medication for ADHD had their medication changed or adjusted by the psychiatrist.
Comorbid Diagnoses
Ninety (68.7%) children had at least 1 comorbid psychiatric diagnosis. Some children (n ϭ 29; 22.2%) had Ͼ1 comorbidity: 23 (17.6%) had 2, 5 (3.8%) had 3, and 1 (0.8%) had 4. Fifty-one (38.9%) children had a comorbid LD, 45 (34.4%) had ODD/CD, and 27 (20.6%) had some other comorbid diagnosis (eg, Tourette's syndrome, sleep disorder, depression, anxiety disorder, communication disorder). The proportion of children with versus without a comorbid diagnosis did not vary by gender and was not related to age.
ADHD Symptom Severity
Parent-reported CSI data were available for 122 (93.1%) children, and teacher-reported CSI data were Mean CHQ-PF50 scores for the ADHD sample and Australian and US population norms appear in Fig 1. The physical health domains for children with ADHD did not vary from either normative sample. All psychosocial health domains, family activities, family cohesion, and the psychosocial summary score were substantially lower in children with ADHD compared with the 2 population samples (all ADHD vs US; P Ͻ.0001).
To estimate the clinical importance of these differences, effect sizes were computed between the ADHD and US samples. The results indicate clinically important deficits in HRQL in all psychosocial domains, family activities, family cohesion, and the psychosocial summary score and in order of magnitude were as follows: family-cohesion ϭ Ϫ0.66, selfesteem ϭ Ϫ0.90, mental health ϭ Ϫ0.97, parental impact-time ϭ Ϫ1.07, role/social limitations emotional-behavioral ϭ Ϫ1.60, general behavior ϭ Ϫ1.73, parental impact-emotional ϭ Ϫ1.87, family activities ϭ Ϫ1.95, and psychosocial summary score ϭ Ϫ1.98.
Correlations Between HRQL and Symptoms of ADHD
Spearman correlations between parent-reported CSI scores and HRQL physical health domains were not significant. Higher ADHD symptom severity was associated with poorer HRQL for all domains of psychosocial health, family activities, and the psychosocial summary score (see Table 2 ). Similar correlations between teacher-reported scores (CSI) and the psychosocial HRQL scores were not statistically significant (all correlations below r ϭ 0.14). Table 3 shows the mean CHQ-PF50 item, domain and summary scores, and 95% confidence intervals by number of comorbid disorders (0, 1, Ն2). Poorer health for those with more comorbidity was apparent for 5 domains of psychosocial health, 2 domains of physical health, family activities, and the psychosocial summary score. The differences in mean scores comparing those with Ն2 comorbidities and those with no comorbidity resulted in large effect sizes (see Table 3 ). No differences were detected when the group with no comorbidity was compared with the group with 1 comorbid disorder. Those with Ն2 comorbid disorders differed significantly from those with no comorbidity in most areas, including role physical, general health, role emotion/behavioral, behavior, mental health, self-esteem, parental impact-time, family activities, and the psychosocial summary score, and from those with 1 comorbid disorder in 3 domains, including behavior, mental health, family activities, and the psychosocial summary score.
HRQL by Number of Comorbid Psychiatric Diagnoses
HRQL by Type of Comorbid Psychiatric Diagnoses
The physical and psychosocial CHQ-PF50 summary scores for children with no comorbid diagnoses were compared with children with an LD, ODD/CD, or other comorbid disorder. Although no differences were found for physical health, the mean score for psychosocial health for children in the ODD/CD group (mean difference: Ϫ12.9; P Ͻ .001; effect size ϭ Ϫ1.11) and children in the other comorbidity group (Ϫ9.0; P ϭ .005; effect size ϭ Ϫ.77) but not children in the LD group were significantly lower than children with no comorbid disorder.
Some children in each of the above groups had Ͼ1 type of comorbid disorder. We therefore compared the psychosocial summary score for smaller groups of children with specific patterns of comorbid disorders to examine the relationship with HRQL. The subgroups included children with only an ODD/CD (n ϭ 21); only an LD (n ϭ 28); only 1 of the other comorbidities (n ϭ 12); both an ODD/CD and an LD (n ϭ 14); and the remaining children (n ϭ 15), who had a mix of 2 or more psychiatric disorders. Children with an ODD/CD scored lower than children with no comorbidity (mean difference: Ϫ13.0; P Ͻ .001) and those with an LD (Ϫ13.4; P ϭ .001). Children with ODD/CD and an LD had lower mean scores than those with no comorbidity (Ϫ10.2; P ϭ .024) and those with an LD (Ϫ10.6; P ϭ .025). Finally, children in the mixed group had lower mean scores than those with no comorbidity (Ϫ13.4; P ϭ .001) and those with an LD (Ϫ13.9; P ϭ .002).
Predictors of HRQL
Predictors that were significant in the final model (n ϭ 121) for physical health containing only the significant bivariate predictors included child's gender (␤ ϭ .177; P ϭ .049) and number of comorbid conditions (␤ ϭ Ϫ.197; P ϭ .028). These 2 variables explained very little variation in physical health.
Predictors that were significant in the final model (n ϭ 93) for psychosocial health included the number of comorbid conditions (␤ ϭ Ϫ.374; P Ͻ .001) and parent-rated combined ADHD symptoms (␤ ϭ Ϫ.362; P Ͻ .001). In the final model, the adjusted R 2 was .31 (F ϭ 32.051, df ϭ 2,90, P Ͻ .0001).
DISCUSSION
In agreement with previous research, 9-12 our study shows that ADHD has a significant impact on multiple domains of HRQL in children and adolescents. Specifically, in support of our first hypothesis, compared with normative data, children with ADHD had more parent-reported problems in terms of emotional-behavioral role function, behavior, mental health, and self-esteem. In addition, the problems of children with ADHD had a significant impact on the parents' emotional health and parents' time to meet their own needs, and they interfered with family activities and family cohesion. No differences were found for aspects of physical health. Researchers have reached a consensus that a minimally important difference in HRQL is close to one half of an SD. 23 The differences that we found (eg, effect size of Ϫ1.98 for the psychosocial summary score) were sub- stantially larger and therefore represent clinically important differences in HRQL. Our study adds new information about the HRQL of children with ADHD for 2 clinical characteristics. First, as hypothesized, HRQL was correlated with parent-reported ADHD symptom severity: children with more ADHD symptoms had poorer HRQL. Parent-reported ADHD symptoms were an important predictor of psychosocial health in the regression model. These findings are a graphic illustration of how ADHD affects health for the child and the family in ways that are broader than is apparent from symptoms alone and that are measurable with appropriate instruments. Although many treatment studies focus simply on measuring a reduction in symptoms using rating scales and checklists, we argue that measurement of these broader domains of family impact and child health be included in clinical and research studies of children with ADHD. In our study, using a multidimensional questionnaire, we were able to show that ADHD symptoms are related to many areas of health of children and their family.
The finding that parent and teacher ratings of ADHD symptoms were poorly correlated is in agreement with other research on this topic. Many researchers have noted that parents and teachers frequently disagree on their assessment of behavioral/emotional problems in children. 19, [24] [25] [26] Such differences do not mean that either reporter is inaccurate, because parents and teachers see the child in different situations and ratings may be affected by many different factors. Often teachers see the children only when they are medicated (in Canada, longacting stimulants have been available only recently), which could help to account for the finding that HRQL was related to parent-reported symptoms but not teacher-reported symptoms. It is also possible that parents may have exaggerated both their child's ADHD symptoms and HRQL in an attempt to secure an appointment.
Second, in support of our hypothesis, an important predictor of psychosocial HRQL was the presence of comorbid psychiatric disorders. We found that children with Ն2 comorbid disorders had poorer psychosocial HRQL in a range of domains compared with children with none and 1 comorbid disorder. Furthermore, at the bivariate level, HRQL was related to the particular type of comorbidity. Compared with children with no comorbidity, psychosocial HRQL was significantly lower in children with an ODD/CD and children in the other comorbidity group but not children with an LD. The effect sizes for these differences were large, indicating clinically important deficits in health. When we separated children into 6 subgroups by comorbidity, we found that compared with children with no comorbidity and children with an LD, psychosocial HRQL was lower in children with only ODD/CD, ODD/CD and LD, and a mix of comorbidity conditions.
Given that comorbidity is common with ADHD 2,3,27 and comorbidity is an important predictor of HRQL in ADHD, the effectiveness of interventions in ADHD, if they are aimed at improving overall health and functioning, should be evaluated using outcome measures that are sensitive to the impact that symptom severity and comorbid disorders have on the overall health and well-being of children. The collection of such information could provide useful information to parents and children who may want to know the likely impact that their child's psychiatric diagnoses will have on his or her health, function, and family life. Our results suggest that whereas the addition of an LD will not make much difference, the addition of an ODD/CD will have clinically important implications for the child and his or her family.
The demonstration in our findings of a differential impact of ADHD on health and well-being in relation to symptom severity and comorbidity has important implications for policies around eligibility for special educational and other supportive services to children and youths with developmental and behavioral disorders. Our findings illustrate a serious flaw in tying service provision to specific medical diagnosis, as happens in many parts of Canada and the United States. It is clear that the impact of ADHD is not uniform, and, hence, decisions about needed supports should incorporate a broader range of functionally relevant indicators.
There are certain limitations to this study. We were not able to compare participants and nonparticipants in terms of clinical variables and therefore do not know the possible direction of bias, if any. We cannot discount the possibility that the low level of HRQL that we found could be attributable to a poorer level of HRQL in our clinic-based sample of children compared with children with ADHD in the general community. Our comparisons with population norms for the CHQ were limited by not having Canadian norms, and we recognize that cross-country comparisons are limited by differences between samples in factors such as socioeconomic status, age, gender, and health care system. Non-English-speaking families were excluded from the study, although our numbers of these were small. HRQL and ADHD symptom data both were provided by parents and therefore represent only 1 perspective. This may account for the strong correlation between HRQL and parent-but not teacher-rated symptoms. Parents were used as proxies, although research shows that parent and child often differ in their ratings of child HRQL. 28, 29 Given the nature of ADHD (ie, children are inattentive, hyperactive, and impulsive, and their parents have a higher prevalence of psychopathology 30, 31 ), research into the validity of self-and proxy report is called for. Finally, because so little is known about the HRQL of children with ADHD, we have provided a comprehensive description of the study sample. Because this necessitated multiple statistical comparisons, the possibility of an ␣ error cannot be discounted.
CONCLUSION
Children with ADHD were found to have substantially lower HRQL compared with normative data. Psychosocial health was related to ADHD symptoms and number of comorbid disorders. HRQL is an important outcome that has received little attention in children with ADHD. The use of tools such as the
